TY - JOUR
T1 - Antibiotic pharmacodynamics in cerebrospinal fluid
AU - Lutsar, Irja
AU - McCracken, George H.
AU - Friedland, Ian R.
N1 - Funding Information:
Publication of this State-of-the-Art Clinical Article has been made possible by an educational grant from Roche Laboratories. Received 14 April 1998; revised 7 July 1998. Reprints or correspondence: Dr. Irja Lutsar, Department of Pediatrics, South-western Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75235-9063.
PY - 1998/11
Y1 - 1998/11
N2 - The CSF half-lives of lipophilic agents, such as quinolones, are similar to those in serum and peak concentrations in CSF are achieved relatively quickly. In contrast, the pharmacokinetics of hydrophilic agents (β-lactams and vancomycin) in CSF often differ from those in serum. In particular, the half-lives of these agents in CSF tend to be extended, and the time to achieve peak concentrations in CSF is delayed. Hydrophilic antibiotics, such as β-lactams, penetrate poorly through the BBB, but CSF penetration is significantly increased in the presence of inflammation. In contrast, lipophilic antibiotics, such as quinolones, enter the CSF more efficiently and their penetration is not inflammation dependent. The pharmacodynamic properties of antibiotics in CSF are generally similar to those in other body sites; β-lactam agents and vancomycin are time-dependent, whereas the quinolones and aminoglycosides are concentration-dependent. However, a notable difference from infections in other sites is that quinolones have a short PAE in CSF and need to continually exceed the MBC for maximal effectiveness. Thus, in CSF, quinolines demonstrate features of both concentration-dependency and time-dependency, evidence that the AUC/MBC is an important predictor of effectiveness. With the exception of quinolones, many antibiotics appear to have prolonged sub-MIC effects and longer half-lives in CSF than in serum, suggesting that dosing intervals longer than those used traditionally would be effective in meningitis. However, this requires clinical verification.
AB - The CSF half-lives of lipophilic agents, such as quinolones, are similar to those in serum and peak concentrations in CSF are achieved relatively quickly. In contrast, the pharmacokinetics of hydrophilic agents (β-lactams and vancomycin) in CSF often differ from those in serum. In particular, the half-lives of these agents in CSF tend to be extended, and the time to achieve peak concentrations in CSF is delayed. Hydrophilic antibiotics, such as β-lactams, penetrate poorly through the BBB, but CSF penetration is significantly increased in the presence of inflammation. In contrast, lipophilic antibiotics, such as quinolones, enter the CSF more efficiently and their penetration is not inflammation dependent. The pharmacodynamic properties of antibiotics in CSF are generally similar to those in other body sites; β-lactam agents and vancomycin are time-dependent, whereas the quinolones and aminoglycosides are concentration-dependent. However, a notable difference from infections in other sites is that quinolones have a short PAE in CSF and need to continually exceed the MBC for maximal effectiveness. Thus, in CSF, quinolines demonstrate features of both concentration-dependency and time-dependency, evidence that the AUC/MBC is an important predictor of effectiveness. With the exception of quinolones, many antibiotics appear to have prolonged sub-MIC effects and longer half-lives in CSF than in serum, suggesting that dosing intervals longer than those used traditionally would be effective in meningitis. However, this requires clinical verification.
UR - http://www.scopus.com/inward/record.url?scp=0032450217&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032450217&partnerID=8YFLogxK
U2 - 10.1086/515003
DO - 10.1086/515003
M3 - Review article
C2 - 9827256
AN - SCOPUS:0032450217
SN - 1058-4838
VL - 27
SP - 1117
EP - 1129
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 5
ER -